Denali Therapeutics Shareholders Equity (Quarterly) Trends

Denali Therapeutics Inc (DNLI)

16.60 -0.22 (-1.31%) USD | NASDAQ | Apr 18, 16:00

16.60 0.00 (0.00%) After-Hours: 20:00

Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	1.031B
September 30, 2023	1.118B
June 30, 2023	1.187B
March 31, 2023	966.71M
December 31, 2022	1.042B
September 30, 2022	811.30M
June 30, 2022	884.45M
March 31, 2022	917.93M
December 31, 2021	962.29M
September 30, 2021	1.012B
June 30, 2021	1.073B
March 31, 2021	1.105B
December 31, 2020	1.151B
September 30, 2020	882.55M

Date	Value
June 30, 2020	502.17M
March 31, 2020	545.31M
December 31, 2019	394.89M
September 30, 2019	438.20M
June 30, 2019	475.17M
March 31, 2019	516.65M
December 31, 2018	546.84M
September 30, 2018	461.18M
June 30, 2018	490.27M
March 31, 2018	539.03M
December 31, 2017	465.80M
September 30, 2017	193.14M
December 31, 2016	-94.15M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

394.89M

Minimum

Dec 2019

1.187B

Maximum

Jun 2023

868.44M

Average

962.29M

Median

Dec 2021

Shareholders Equity (Quarterly) Benchmarks

Halozyme Therapeutics Inc	83.81M
AIM ImmunoTech Inc	10.23M
Perspective Therapeutics Inc	75.18M
Protalix BioTherapeutics Inc	33.57M
Armata Pharmaceuticals Inc	-32.06M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly)	1.154B
Total Liabilities (Quarterly)	122.96M